Dell Seton Medical Center at The University of Texas is a hospital on the property of the Dell Medical School in Austin, Texas. It is the teaching hospital for the medical school. It is on land owned by the University of Texas at Austin.

During the past decade, Dell Seton Medical Center at The University of Texas conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 17 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 16 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dell Seton Medical Center at The University of Texas" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "University of Texas at Austin" with 4 trials sponsored, "GOG Foundation" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dell Seton Medical Center at The University of Texas" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Dell Seton Medical Center at The University of Texas" are "Invasive Breast Carcinoma" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Dell Seton Medical Center at The University of Texas" in a lesser frequency.

Most popular intervention types in "Dell Seton Medical Center at The University of Texas" are "Other" (40 trials), "Drug" (37 trials), "Biological" (17 trials), "Procedure" (9 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (14 trials), "Questionnaire Administration" (8 trials), "Cisplatin" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Dell Seton Medical Center at The University of Texas" are 37 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Dell Seton Medical Center at The University of Texas". 1 are not yet recruiting, 14 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Dell Seton Medical Center at The University of Texas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dell Seton Medical Center at The University of Texas, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".